(Q30425939)

21 June 2017

title

The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance (English)

1 reference

21 June 2017

0 references

Stephan Ludwig

14

0 references

author name string

Christina Ehrhardt

1

1 reference

21 June 2017

Andrea Rückle

2

1 reference

21 June 2017

Eike R Hrincius

3

1 reference

21 June 2017

Emanuel Haasbach

4

1 reference

21 June 2017

Darisuren Anhlan

5

1 reference

21 June 2017

Katharina Ahmann

6

1 reference

21 June 2017

Carina Banning

7

1 reference

21 June 2017

Sarah J Reiling

8

1 reference

21 June 2017

Joachim Kühn

9

1 reference

21 June 2017

Stefan Strobl

10

1 reference

21 June 2017

Daniel Vitt

11

1 reference

21 June 2017

Johann Leban

12

1 reference

21 June 2017

Oliver Planz

13

1 reference

21 June 2017

publication date

5 February 2013

1 reference

21 June 2017

published in

Cellular Microbiology

1 reference

21 June 2017

volume

15

1 reference

21 June 2017

issue

7

1 reference

21 June 2017

page(s)

1198-1211

1 reference

The Ebola virus VP35 protein functions as a type I IFN antagonist.

21 June 2017

cites work

1 reference

CyProQuant-PCR: A real time RT-PCR technique for profiling human cytokines, based on external RNA standards, readily automatable for clinical use

21 January 2018

1 reference

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

21 January 2018

1 reference

Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3.

21 January 2018

1 reference

A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance

21 January 2018

1 reference

Statins for infection and sepsis: a systematic review of the clinical evidence

21 January 2018

1 reference

Caspases disrupt the nuclear-cytoplasmic barrier

21 January 2018

1 reference

Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection

21 January 2018

1 reference

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

21 January 2018

1 reference

Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase

21 January 2018

1 reference

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response

21 January 2018

1 reference

Universal primer set for the full-length amplification of all influenza A viruses

21 January 2018

1 reference

Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway

21 January 2018

1 reference

PAR1 contributes to influenza A virus pathogenicity in mice

21 January 2018

1 reference

Statins for sepsis: a critical and updated review

21 January 2018

1 reference

Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina

21 January 2018

1 reference

NF-kappaB signaling differentially regulates influenza virus RNA synthesis

21 January 2018

1 reference

Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway

21 January 2018

1 reference

MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

21 January 2018

1 reference

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

21 January 2018

1 reference

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

21 January 2018

1 reference

Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression

21 January 2018

1 reference

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

21 January 2018

1 reference

The effect of rosuvastatin in a murine model of influenza A infection

21 January 2018

1 reference

Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice

21 January 2018

1 reference

21 January 2018

Caspases: enemies within

1 reference

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

21 January 2018

1 reference

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

21 January 2018

1 reference

Caspase 3 activation is essential for efficient influenza virus propagation

21 January 2018

1 reference

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CMI.12108

1 reference

release_lcylbewg4fca7lmi63eky45r54

21 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lcylbewg4fca7lmi63eky45r54

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference